Collagen I, III and IV content in airways and lung parenchyma of COPD patients Source: Annual Congress 2010 - Proteases and the matrix Year: 2010
Parameters of sIgE and sIgG4-autoAbs to lung elastin, collagen type III and myosin in bronchial asthma in association with chronic infection. Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019
Type I and III collagen protein precursors in the airways of smokers and COPD-patients Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008
Increased expression of SARS-CoV-2 (Covid-19) adhesion sites on type II pneumocytes, small airway epithelium, and alveolar macrophages in smokers and patients with COPD Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021
Changes in elastic fibres in the small airways and alveoli in COPD Source: Eur Respir J 2008; 31: 998-1004 Year: 2008
Collagen content in human pulmonary emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 250s Year: 2001
Aging causes alveolar epithelial type II cell dysfunction in acute lung injury Source: ERS Lung Science Conference 2020 Year: 2020
Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosis Source: Eur Respir J 2015; 45: 1393-1402 Year: 2015
Extracellular matrix molecules are differentially associated with airflow obstruction and lung parenchymal destruction in COPD Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD Year: 2019
Update on the roles of distal airways in COPD Source: Eur Respir Rev 2011; 20: 7-22 Year: 2011
Changes in bronchial mucous membrane depending on the stage of COPD (I, II) Source: Annual Congress 2011 - COPD mechanisms Year: 2011
Is lung emphysema in COPD patients reflected by central airways inflammation? Source: Eur Respir J 2003; 22: Suppl. 45, 207s Year: 2003
Comparable matrix alterations in the alveolar and small airway wall of COPD patients Source: Annual Congress 2012 - Basic and translational studies in COPD Year: 2012
Airway gene expression identifies subtypes of Type 2 inflammation in severe asthma Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes Year: 2020
Decreased expression of TGFβ1 type II receptor in bronchial glands of smokers with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 98s Year: 2004
Pertechnegas lung clearance in different forms of interstitial lung disease Source: Eur Respir J 2002; 19: 31-36 Year: 2002
Polymorphisms in the type IV collagen alpha3 gene and the risk of COPD Source: Eur Respir J 2008; 32: 35-41 Year: 2008
Expression of versican in large and small airways and parenchyma in lungs of non-smokers, smokers and COPD patients Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury Year: 2009
Expression of type 1 and type 2 cytokines in central airways of smokers with chronic bronchitis Source: Eur Respir J 2001; 18: Suppl. 33, 74s Year: 2001
Increased urotensin II in BALF and lung tissue in rat model of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 216s Year: 2006